Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - arsenic (unii: n712m78a8g) (arsenic - unii:n712m78a8g) - arsenic 8 [hp_x] - constipation, coryza condition listed above or as directed by the physician

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide 6 [hp_x] - uses: temporary relief - vomitings, stomach upsets* * claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. condition listed above or as directed by the physician

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - arsenic triiodide (unii: 3029988o2t) (arsenic cation (3+) - unii:c96613f5av) - arsenic triiodide 6 [hp_x] - hay fever, coryza condition listed above or as directed by the physician

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - arsenic trisulfide (unii: 44sij800ox) (arsenic cation (3+) - unii:c96613f5av) - arsenic trisulfide 6 [hp_x] - acne, eczema, boils condition listed above or as directed by the physician

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

true botanica, llc - arsenic (unii: n712m78a8g) (arsenic - unii:n712m78a8g) - arsenic 30 [hp_x] in 23 g - enter section text here for temporary relief of burning pains, agitation, restlessness. may also be used for standard homeopathic indications or as directed by your physician. tamper evident: do not use if safety seal is broken before first use.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

zydus lifesciences limited - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide injection is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. arsenic trioxide is contraindicated in patients who are hypersensitive to arsenic. risk summary based on the mechanism of action [see clinical pharmacology (12.1)] and findings in animal studies, arsenic trioxide can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m2 basis (see data) . a related trivalent arsenic, sodium arsenite, produced teratogenicity when administered during gestation in mice at a dose approximately 5 times the projected human dose on a mg/m2 basis and in hamsters at an intravenous d

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

sti pharma llc - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide injection is indicated for induction of remission and consolidation in patients with apl who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. arsenic trioxide for injection is contraindicated in patients who are hypersensitive to arsenic. risk summary based on the mechanism of action [see clinical pharmacology ( 12.1) ] and findings in animal studies, arsenic trioxide injection can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m 2 basis ( see data ). a related trivalent arsenic, sodium arsenite, produced teratogenicity when

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

zydus lifesciences limited - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide injection is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. arsenic trioxide is contraindicated in patients who are hypersensitive to arsenic. risk summary based on the mechanism of action [see clinical pharmacology (12.1)] and findings in animal studies, arsenic trioxide can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m2 basis (see data) . a related trivalent arsenic, sodium arsenite, produced teratogenicity when administered during gestation in mice at a dose approximately 5 times the projected human dose on a mg/m2 basis and in hamsters at an intravenous d

Canada - engleză - Health Canada

sandoz canada incorporated - arsenic trioxide - solution - 10mg - arsenic trioxide 10mg - antineoplastic agents

Israel - engleză - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - arsenic trioxide - concentrate for solution for infusion - arsenic trioxide 1 mg / 1 ml - arsenic trioxide - arsenic trioxide s.k. is indicated for induction of remission, and consolidation in adult patients with: •newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10x1000µl incombination with all-trans-retinoic acid (atra) •relapsed/refractory acute promyelocytic leukaemia (apl)(previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rar-alpha) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.